Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Summary

The goal of this clinical research study is to learn if decitabine (given at 3 different doses) can help to control Myelodysplastic Syndrome (MDS). The safety of these 3 treatments will also be studied.

Timeline

Start

2003-10

Primary completion

2009-05

Completion

2009-05

Publications

• Oki Y, Jelinek J, Shen L, Kantarjian HM, Issa JP. Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood. 2008 Feb 15;111(4):2382-4. doi: 10.1182/blood-2007-07-103960. Epub 2007 Nov 30.

Drugs

Indications